Stantec to acquire Morrison Hershfield, a leading transportation, buildings, and environmental services firm
EDMONTON, Alberta and NEW YORK and MARKHAM, Ontario, Jan. 09, 2024 (GLOBE NEWSWIRE) — TSX, NYSE: STN Stantec, a global […]
Radisson Identifies New Gold Target Area with more than 2 km Strike Length at the New Alger Area
ROUYN-NORANDA, Quebec, Jan. 09, 2024 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTCQB: RMRDF) (“Radisson” or the “Company”) […]
Azimut and SOQUEM Announce Major Drill Intercept in First Hole on Galinée: 2.48% Li2O over 72.7 metres
LONGUEUIL, Quebec, Jan. 09, 2024 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to […]
Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement
A New Choice for Bariatric Surgeons: Titan SGS™Standard Staple Line Reinforcement with GORE®SEAMGUARD®Bioabsorbable Staple Line Reinforcement WAYNE, Pa., Jan. 09, 2024 (GLOBE [...]
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
IRVINE, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]
TSX News -
K92 Mining Announces Record Quarterly Production of 39,101 oz AuEq, Multiple Operational Records and Exceeds Annual Production Guidance
Record quarterly production of 39,101 ounces gold equivalent (“AuEq”)(1)or 33,309 oz gold, 2,728,623 lbs copper and 56,502 oz silver, and […]
TSX News -
Calibre Delivers Record Full Year 2023 Gold Production of 283,494 Ounces, Exceeding the High End of Guidance; Setting Up for Stronger 2024 With Production Guidance of 275,000 – 300,000 Ounces
VANCOUVER, British Columbia, Jan. 09, 2024 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) […]
ACM Research Updates 2023 Revenue Outlook and Provides Initial Outlook for 2024 Revenue
—Updates 2023 Revenue Outlook to $530 to $545 Million— —Projected 2024 Revenue of $650 to $725 Million— —ACM to Participate […]
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
Data showed ELI-002 administered as a monotherapy induced robust, polyfunctional and durable KRAS specific CD4+ and CD8+ T cell responses […]
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a […]
